Innovative Water Vapor Technology AEGEA Medical's core product, the Vapor System, leverages water vapor for minimally invasive treatment of menorrhagia, highlighting the company's expertise in natural tissue elimination and women’s health solutions.

Strong Industry Backing The company has received significant venture capital investments, including a total of over $83 million raised through multiple funding rounds from prominent investors like Perceptive Advisors and Delphi Ventures, demonstrating investor confidence and market validation.

Recent Acquisition Advantage In 2021, AEGEA Medical was acquired by CooperSurgical, a division of CooperCompanies, positioning the company's innovative technology within a broader portfolio of women’s health and medical devices for increased market reach and distribution channels.

Regulatory and Clinical Progress The company has generated positive clinical data and launched long-term post-market studies, which can support credibility with healthcare providers and facilitate regulatory approvals in new markets.

Niche Focused Market Targeting the women’s health sector with specialized endometrial ablation devices, AEGEA Medical operates in a growing segment with high clinical demand for minimally invasive, safe, and effective treatment options, offering avenues for expanding sales through clinics and hospitals.